Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
30.92
+1.19 (+4.00%)
Streaming Delayed Price
Updated: 11:29 AM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
22
23
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
Viking Therapeutics Unusual Options Activity For March 19
March 19, 2024
Via
Benzinga
Warning: This Skyrocketing Stock Has a Hidden Risk
March 19, 2024
Don't bet on this pitfall happening, but know that it's a possibility.
Via
The Motley Fool
Where Will Viking Therapeutics Be in 5 Years?
March 17, 2024
Expectations for the stock are high, and it could well deliver.
Via
The Motley Fool
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
Will Viking Therapeutics Get Acquired?
March 16, 2024
Would an acquisition be good news for Viking Therapeutics investors?
Via
The Motley Fool
Check Out What Whales Are Doing With VKTX
March 14, 2024
Via
Benzinga
Peering Into Viking Therapeutics's Recent Short Interest
March 13, 2024
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $900 Today
March 11, 2024
Via
Benzinga
2 Stocks That Have More Than Tripled This Year: Are They Buys?
March 15, 2024
Don't jump on the bandwaggon too quickly.
Via
The Motley Fool
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
Viking Therapeutics just might be an attractive acquisition target for Pfizer.
Via
The Motley Fool
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March
March 13, 2024
This environment presents a compelling opportunity for investors seeking growth. Discover 3 top stocks primed for long-term growth in 2024.
Via
InvestorPlace
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
March 13, 2024
Viking aims to enter a market that may be worth $100 billion in a few years.
Via
The Motley Fool
Is Viking Therapeutics Stock a Buy?
March 11, 2024
Its potential is looking increasingly more likely to be realized.
Via
The Motley Fool
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
March 12, 2024
The pharma giant could have yet another knockout obesity drug on the way.
Via
The Motley Fool
What's Going On With Viking Therapeutics (VKTX) Stock?
March 11, 2024
Viking Therapeutics shares are trading lower by 10.9% Monday afternoon. The stock has experienced marked volatility following a number of key company announcements in February.
Via
Benzinga
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
March 09, 2024
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
Via
The Motley Fool
3 Stock Winners That Are Up 1,000% or More in 2024
March 08, 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.
Via
InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 07, 2024
Via
Benzinga
Why Viking Therapeutics Stock Is Plunging Today
March 07, 2024
The sell-off could present a buying opportunity for aggressive investors willing to bet that the obesity market will be big enough for multiple winners.
Via
The Motley Fool
Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug
March 07, 2024
Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
March 06, 2024
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher
Via
MarketBeat
Exposures
Product Safety
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
March 06, 2024
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.
Via
The Motley Fool
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
March 05, 2024
Here's why I'm not worried.
Via
The Motley Fool
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
March 05, 2024
One is a reigning champion, and the other is a burgeoning contender.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.